Advisors Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Advisors Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Buy	2,489 +241	+11%	+$24.7K	﹤0.01%	1117
2026 Q1	$245K	Sell	2,248 -374	-14%	-$35.6K	﹤0.01%	1110
2025 Q4	$213K	Sell	2,622 -712	-21%	-$61.3K	﹤0.01%	1123
2025 Q3	$292K	Sell	3,334 -777	-19%	-$69.4K	0.01%	1066
2025 Q2	$341K	Buy	4,111 +118	+3%	+$9.86K	0.01%	1031
2025 Q1	$335K	Buy	3,993 +773	+24%	+$71.9K	0.01%	1020
2024 Q4	$297K	Buy	3,220 +1,368	+74%	+$132K	0.01%	1043
2024 Q3	$172K	Buy	1,852 +1,191	+180%	+$103K	﹤0.01%	1130
2024 Q2	$54.4K	Buy	+661	New	+$48.6K	﹤0.01%	1274

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Advisors Asset Management's LMAT Position: Q2 2026 in Review

Advisors Asset Management increased its LeMaitre Vascular (LMAT) stake by 11% in Q2 2026, buying an estimated $24.7K and bringing the position to 2,489 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Advisors Asset Management first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $341K in Q2 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Advisors Asset Management held 2,489 shares of LeMaitre Vascular worth $239K as of Q2 2026.
Advisors Asset Management bought 241 LeMaitre Vascular shares in Q2 2026, an estimated $24.7K.
LeMaitre Vascular made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1117 holding.
Advisors Asset Management first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
Advisors Asset Management's LeMaitre Vascular position peaked at $341K in Q2 2025.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.